BRITTANY LACY: Open Payments
NPI 1508282955 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 36 payments from 14 companies in 2025. Trend: 2023 $439 · 2024 $628 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $183 |
| Novo Nordisk Inc | 3 | $50 |
| Lilly USA, LLC | 3 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| PFIZER INC. | 2 | $32 |
| Exact Sciences Corporation | 2 | $31 |
| Antares Pharma, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: VRAYLAR, QULIPTA, TRELEGY ELLIPTA, Rybelsus, UBRELVY, MOUNJARO, REXULTI, FARXIGA.
Industry payments across AR — which companies pay providers there.
